FLT3 and acute myeloid leukemia: FLT3 mutations have been found in ~25% of paediatric patients and ~30% of adult patients [105], with some studies suggesting that successful targeting of unmutated FLT3 could lead to ~80% of AML patients being treated with one approach [106,107].